Product image of Tagrisso (Osimertinib) supplied by GNH India

Tagrisso

Active Ingredient:
Osimertinib
Origin:
EU

Tagrisso (Osimertinib)

Tagrisso (osimertinib) is an oral medication used to treat certain types of non-small cell lung cancer. This targeted therapy helps slow cancer progression by blocking abnormal signals in cancer cells. Suitable for patients with specific genetic mutations, it is prescribed under medical supervision.

Manufacturer / TM Owner

Astrazeneca Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Tagrisso (osimertinib) is primarily used to treat non-small cell lung cancer (NSCLC) in patients with specific genetic mutations, such as EGFR T790M. It may also be prescribed for other EGFR mutation-positive lung cancers as determined by a healthcare provider. This medication is designed to target cancer cells while minimizing damage to healthy cells.

Side Effects

  • Tagrisso (osimertinib) works by interfering with signals that promote cancer cell growth, helping to slow or stop tumor progression. Patients may experience improved symptoms related to lung cancer, such as reduced coughing or shortness of breath. Individual responses vary, and effects should be monitored by a healthcare professional.

Precautions & Warnings

  • Tagrisso should be taken exactly as prescribed by a doctor, typically once daily. Patients should inform their healthcare provider about all medications, supplements, and medical conditions before starting treatment. Regular check-ups and monitoring may be required to assess effectiveness and manage side effects.

Avoid Interactions

  • Certain medications, including strong CYP3A4 inhibitors or inducers, may interact with Tagrisso, potentially affecting its effectiveness or increasing side effects. Patients should avoid grapefruit products while taking this medication. Alcohol use and other drugs should be discussed with a healthcare provider to prevent adverse interactions.

Frequently Asked Questions

Tagrisso is used to treat certain types of non-small cell lung cancer, particularly those with EGFR mutations like T790M.

Tagrisso is an oral medication, typically taken once daily as prescribed by a doctor.

Common side effects may include diarrhea, rash, dry skin, or fatigue. Patients should report persistent or severe symptoms to their healthcare provider.

Alcohol use should be discussed with a healthcare provider, as it may interact with the medication or worsen side effects.

No, Tagrisso is a targeted therapy, not a traditional chemotherapy drug. It works by blocking specific signals in cancer cells.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Osimertinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT